BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

303 related articles for article (PubMed ID: 17215417)

  • 1. Patterns of psychotropic drug prescription for U.S. patients with diagnoses of bipolar disorders.
    Baldessarini RJ; Leahy L; Arcona S; Gause D; Zhang W; Hennen J
    Psychiatr Serv; 2007 Jan; 58(1):85-91. PubMed ID: 17215417
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence.
    Baldessarini R; Henk H; Sklar A; Chang J; Leahy L
    Psychiatr Serv; 2008 Oct; 59(10):1175-83. PubMed ID: 18832504
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacological Treatment Patterns at Study Entry for the First 500 STEP-BD Participants.
    Ghaemi SN; Hsu DJ; Thase ME; Wisniewski SR; Nierenberg AA; Miyahara S; Sachs G
    Psychiatr Serv; 2006 May; 57(5):660-5. PubMed ID: 16675760
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The use of lithium, valproate or lamotrigine for psychiatric conditions in children and adolescents in Norway 2004-2007 - a prescription database study.
    Bramness JG; Grøholt B; Engeland A; Furu K
    J Affect Disord; 2009 Oct; 117(3):208-11. PubMed ID: 19189871
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Rational polypharmacy in the bipolar affective disorders.
    Post RM; Ketter TA; Pazzaglia PJ; Denicoff K; George MS; Callahan A; Leverich G; Frye M
    Epilepsy Res Suppl; 1996; 11():153-80. PubMed ID: 9294735
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Therapeutic management of bipolar disorder in France and Europe: a multinational longitudinal study (WAVE-bd)].
    Bellivier F; Delavest M; Coulomb S; Figueira ML; Langosch JM; Souery D; Vieta E
    Encephale; 2014 Oct; 40(5):392-400. PubMed ID: 25238903
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prevalence of bipolar disorder diagnoses and psychotropic drug therapy among privately insured children and adolescents.
    Dusetzina SB; Weinberger M; Gaynes BN; Farley JF; Sleath B; Hansen RA
    Pharmacotherapy; 2012 Dec; 32(12):1085-94. PubMed ID: 23208835
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Psychotropic polypharmacy for the treatment of bipolar disorder in Taiwan.
    Hung GC; Yang SY; Chen Y; Lin SK
    Psychiatr Serv; 2014 Jan; 65(1):125-8. PubMed ID: 24382766
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current psychotropic medication prescribing patterns in late-life bipolar disorder.
    Rej S; Herrmann N; Shulman K; Fischer HD; Fung K; Gruneir A
    Int J Geriatr Psychiatry; 2017 Dec; 32(12):1459-1465. PubMed ID: 27911003
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Pharmacological treatment of acute mania in psychiatric in-patients between 1994 and 2004.
    Wolfsperger M; Greil W; Rössler W; Grohmann R
    J Affect Disord; 2007 Apr; 99(1-3):9-17. PubMed ID: 16989907
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Psychotropic use and risk of stroke among patients with bipolar disorders: 10-year nationwide population based study.
    Wu CS; Wu KY; Lo YR; Huang YW; Tsai YT; Li Y; Tsai HJ
    J Affect Disord; 2018 Jan; 226():77-84. PubMed ID: 28964996
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Treatment-refractory bipolar disorder: classification to aid in clinical management.
    Gajwani P
    Expert Opin Pharmacother; 2009 Aug; 10(12):1907-15. PubMed ID: 19606936
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Risk of recurrence in women with bipolar disorder during pregnancy: prospective study of mood stabilizer discontinuation.
    Viguera AC; Whitfield T; Baldessarini RJ; Newport DJ; Stowe Z; Reminick A; Zurick A; Cohen LS
    Am J Psychiatry; 2007 Dec; 164(12):1817-24; quiz 1923. PubMed ID: 18056236
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Changes in mood stabilizer prescription patterns in bipolar disorder.
    Karanti A; Kardell M; Lundberg U; Landén M
    J Affect Disord; 2016 May; 195():50-6. PubMed ID: 26859073
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Drug treatment for patients with bipolar disorders in psychiatric practices in Germany in 2009 and 2018.
    Bohlken J; Bauer M; Kostev K
    Psychiatry Res; 2020 Jul; 289():112965. PubMed ID: 32388174
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mono- and combination drug therapies in hospitalized patients with bipolar depression. Data from the European drug surveillance program AMSP.
    Haeberle A; Greil W; Russmann S; Grohmann R
    BMC Psychiatry; 2012 Sep; 12():153. PubMed ID: 22998655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Association between mood-stabilizing medication and mental health resource use in the management of acute mania.
    Sajatovic M; Gerhart C; Semple W
    Psychiatr Serv; 1997 Aug; 48(8):1037-41. PubMed ID: 9255836
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Trends in the psychopharmacological treatment of bipolar disorder: a nationwide register-based study.
    Bjørklund L; Horsdal HT; Mors O; Østergaard SD; Gasse C
    Acta Neuropsychiatr; 2016 Apr; 28(2):75-84. PubMed ID: 26357986
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes mellitus risk for 102 drugs and drug combinations used in patients with bipolar disorder.
    Nestsiarovich A; Kerner B; Mazurie AJ; Cannon DC; Hurwitz NG; Zhu Y; Nelson SJ; Oprea TI; Crisanti AS; Tohen M; Perkins DJ; Lambert CG
    Psychoneuroendocrinology; 2020 Feb; 112():104511. PubMed ID: 31744781
    [TBL] [Abstract][Full Text] [Related]  

  • 20. A prospective 4-year naturalistic follow-up of treatment and outcome of 300 bipolar I and II patients.
    Simhandl C; König B; Amann BL
    J Clin Psychiatry; 2014 Mar; 75(3):254-62; quiz 263. PubMed ID: 24717379
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.